This blog includes:
- Examination of 21 CFR Part 11
- Breakdown of the Components of 21 CFR Part 11
- Understanding the Importance and Necessity
Table of Contents:
- Introduction
- Scope
- What is 21 CFR Part 11?
- Who comes under this regulation applicable?
- Who Does This Regulation Apply To?
- Requirements for Part 11
- Implementation Necessities for 21 CFR Part 11
- Key Takeaways
- Conclusion
- References
Introduction
Welcome to this informative blog, dedicated to explaining the nuances of implementing 21 CFR Part 11 in your organization. Before diving into implementation, it’s crucial to grasp the important details, which is exactly what this blog offers.
Scope of 21 CFR Part 11
In this section, we’ll highlight key points regarding this regulation, including:
- Ensuring secure document transfer between parties, equivalent to traditional handwritten signatures.
What is 21 CFR Part 11?
21: This refers to “Title 21,” a section of the CFR (Code of Federal Regulations) pertaining to food and drugs.
CFR: “Code of Federal Regulations,” a collection of laws published by the U.S. federal government, comprising 50 titles.
Part 11: Specifically addresses electronic records and electronic signatures, including their submission to the FDA.
21 CFR Part 11 outlines guidelines for the use, maintenance, and implementation of electronic records and electronic signatures. Issued by the FDA, this regulation facilitates the substitution of electronic records and signatures for handwritten ones.
“An audit is not an inspection; it is a collaborative opportunity to ensure compliance and identify areas for improvement, essential in the context of regulations like 21 CFR Part 11.”
Who comes under this regulation applicable?
This regulation applicable particularly for pharmaceuticals, Bio-pharmaceuticals and medical devices.
Moreover, This part also applies to electronic records submitted to the agency under requirements of the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, even if such records are not specifically identified in agency regulations.
Who Does This Regulation Apply To?
This regulation specifically applies to
- Pharmaceuticals
- Biopharmaceuticals and
- Medical devices.
Additionally, it extends to electronic records submitted to the agency under the requirements of the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, regardless of whether such records are explicitly mentioned in agency regulations.
Part 11 Requirements
The guidelines set forth in Part 11 are highly specific, mandating that electronic records must be:
- Trustworthy
- Reliable
- Equivalent to paper records
- Electronic signatures must hold legal validity
These requirements encompass system validations, audit trails, electronic record copies, and controls for electronic signatures.
Implementation Necessities for 21 CFR Part 11
To comply with 21 CFR Part 11, the following implementations are necessary:
- Records must need to be transferable and submitted through a secure gateway to the relevant parties.
- Systems must ensure:
- Authenticity
- Integrity
- Confidentiality (when applicable)
- Irrefutability (i.e., the record’s authenticity cannot be denied)
- When an electronic record is signed, the system must display:
- Printed name of the signer
- Date and time of signature
- Meaning of signature (e.g., attesting to accuracy, verifying format, confirming data calculations)
- Electronic signatures must hold authoritative weight.
✍️ Note: Electronic signatures are not considered bio-metric.
Key Takeaways
These key takeaways succinctly summarize crucial points for better understanding.
- Trustworthiness is paramount when implementing electronic signatures within your organization.
- The FDA recognizes electronic signatures as valid substitutes for paper and ink signatures.
- Signatures must encompass all the components outlined previously.
- Each individual or organization’s signature should be unique.
- Prior notification to the FDA is necessary before transitioning from paper to electronic records.
- Robust security measures and a unique passcode system are vital to safeguarding the passwords and login credentials associated with your signature files.
- The FDA does not oppose the archival of necessary records in electronic format to non-electronic media or standard electronic file formats, provided that all formats comply with regulatory requirements.
Conclusion
This concise and informative blog sheds light on the importance of implementing 21 CFR Part 11 within your organization.
As you embark on the journey of starting up your business, complying with FDA requirements is crucial. With 21 CFR Part 11 being a mandatory aspect, it’s imperative to stay vigilant, as every inspection and audit will scrutinize this compliance.
Keep it on your radar to ensure smooth operations and regulatory adherence.
Feel free to add any important points that may have been missed in this blog. Your input is valuable for enhancing the comprehensiveness of the content.
Leave a Reply